| Unique ID issued by UMIN | UMIN000054149 |
|---|---|
| Receipt number | R000061835 |
| Scientific Title | Milrinone versus dobutamine as supportive agent for right ventricular dysfunction after cardiopulmonary bypass: a prospective randomized comparative study |
| Date of disclosure of the study information | 2024/04/16 |
| Last modified on | 2026/05/04 19:47:20 |
Milrinone versus dobutamine as supportive agent for right ventricular dysfunction after cardiopulmonary bypass: a prospective randomized comparative study
Milrinone versus dobutamine as supportive agent for right ventricular dysfunction after cardiopulmonary bypass
Milrinone versus dobutamine as supportive agent for right ventricular dysfunction after cardiopulmonary bypass: a prospective randomized comparative study
Milrinone versus dobutamine as supportive agent for right ventricular dysfunction after cardiopulmonary bypass
| Africa |
active
| Cardiology | Anesthesiology |
Others
NO
The objective of this study was to compare milrinone and dobutamine regarding their efficacy and safety in managing RV dysfunction after cardiopulmonary bypass during cardiac surgery.
Safety,Efficacy
Exploratory
Echocardiographic RV function indices TAPSE
Other echocardiographic parameters RVFAC, PASP, LVOT VTI
Duration of mechanical ventilation
Length of ICU stay
Incidence of significant arrhythmias (new onset AF, VT) requiring intervention
Incidence of profound hypotension (MAP <55 mmHg) requiring rescue therapy
Need for additional inotropic or vasopressor support
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Active
2
Treatment
| Medicine |
Milrinone group (M group) will include patients who will be subjected to milrinone a loading dose of milrinone acetate 50 mic/kg over 10 minutes followed by 0.3-0.8 mic/kg/min. infusion.
Dobutamine group (D group) will include patients who will be subjected to 2-10 mic/kg/min intravenous infusion.
| 18 | years-old | <= |
| 70 | years-old | >= |
Male and Female
Adult patients over 18 years scheduled for on pump cardiac surgery who developed new RV systolic dysfunction after CPB separation were eligible. RV dysfunction was defined as TAPSE less than 17 mm on intraoperative echocardiography together with clinical signs requiring inotropic support persistent hypotension and elevated CVP. Enrolment occurred when the clinical team decided to initiate inotropic therapy during or immediately after CPB weaning
Emergency surgery
Prior intake of inotropic support.
Severe hepatic, renal impairment.
Patients for pulmonary thromboendarterectomy,
Contraindication for use of TEE
88
| 1st name | Mohammed |
| Middle name | Adel |
| Last name | Hegazy |
Mansoura university
anesthesia and surgical intensive care department
35511
Anesthesia and ICU faculty of Medicine Mansoura University
0020502205178
dr_mhegazy7000@mans.edu.eg
| 1st name | mohammed |
| Middle name | adel |
| Last name | hegazy |
Mansoura university hospital
anesthesia and surgical intensive care department
35511
Anesthesia and ICU faculty of Medicine Mansoura University
0020502205178
dr_mhegazy7000@mans.edu.eg
Mansoura university hospitals
Mansoura university hospitals
Government offices of other countries
Institutional Research Board - IRB Faculty of Medicine - Mansoura University
institutional review board office - building A ground floor faculty of medicine Mansoura university
00201092127930
IRB,MFM@hotmail.com
NO
| 2024 | Year | 04 | Month | 16 | Day |
Unpublished
Completed
| 2024 | Year | 04 | Month | 10 | Day |
| 2024 | Year | 01 | Month | 11 | Day |
| 2025 | Year | 01 | Month | 15 | Day |
| 2026 | Year | 02 | Month | 15 | Day |
| 2024 | Year | 04 | Month | 14 | Day |
| 2026 | Year | 05 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061835